Sept 20 (Reuters) - A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & Co (MRK.N), opens new tab failed to warn that its osteoporosis drug Fosamax increased the risk ...

The Supreme Court seemed inclined Monday to side with drugmaker Merck & Co. in a dispute over the warning label on its bone-strengthening drug Fosamax. The justices heard arguments in a case involving ...

If you’re one of the 8 million American women with osteoporosis, your doctor has probably talked to you about treatment options to slow the disease’s progression and keep your bones in tip-top shape.

The U.S. Supreme Court on Monday denied a petition for a writ of certiorari filed by the drug company Merck Sharp & Dohme Corp., bringing to a close a decade-long legal battle that had stalled ...

For more than a decade, Merck has been defending itself against claims its osteoporosis drug Fosamax caused patients to suffer “atypical femoral fractures," even taking its fight to the Supreme Court, ...

Two recent reports have linked the osteoporosis drug alendronate (Fosamax) with rare but serious side effects. In a letter to the New England Journal of Medicine published Jan. 1, a Food and Drug ...

Last month, the Third Circuit issued another appellate opinion in the long-gestating In re Fosamax litigation (3d Cir Sept. 20, 2024, – F. 4th, 2024 WL 4247311). The litigation, now well into its ...

NEW YORK (Reuters Health) - The results of a new study suggest that Actonel (risedronate) provides greater fracture protection in the first year of therapy than does Fosamax (alendronate). Among ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Roach • I have read in your previous columns that you have been cautionary about taking medications like Fosamax. I hope ...

DEAR DR. ROACH: I am a 74-year-old man. I have a DEXA score of -3.3. I take 1,200 mg of calcium with vitamin D daily. I lift weights and swim two to three times a week. My doctor put me on Prolia, and ...

The ruling brings an end to roughly 500 suits in litigation that has been ongoing since 2008 and has made a stop at the U.S. Supreme Court. Big Pharma scored a victory on Wednesday when a federal ...

TRENTON, N.J. — At least three generic versions of the popular osteoporosis treatment Fosamax are headed for pharmacy shelves with the expiration of the drug’s main patent Wednesday, bringing patients ...